title: A rare consequence of malignant hypertension.
authors.forename: Pei
authors.initials: P
authors.lastname: Chew
authors.forename: Joseph
authors.initials: J
authors.lastname: Stone
authors.forename: Aleem
authors.initials: A
authors.lastname: Khand
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D004452:Echocardiography; D004617:Embolism / Q000209:etiology / Q000517:prevention & control*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology; D014854:Lateral Medullary Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D018810:Magnetic Resonance Angiography; D008297:Male; D008526:Medulla Oblongata / Q000473:pathology / Q000503:physiopathology; D014711:Vertebral Artery / Q000473:pathology / Q000503:physiopathology; D020217:Vertebral Artery Dissection / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D000925:Anticoagulants; D000959:Antihypertensive Agents; D014859:Warfarin; D006493:Heparin